This article may contain affiliate links. PerformixHouse.com may earn a commission on purchases made through these links, at no additional cost to you. This does not influence our editorial evaluations. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Longevity Supplements and Drug Interactions: Metformin, Rapamycin, Senolytic Stacking Safety
Longevity-focused biohackers increasingly combine prescription drugs and supplements targeting aging pathways: metformin (diabetes/longevity drug), rapamycin analogs (immunosuppressants with anti-aging properties), and senolytic compounds (clearing senescent cells). However, these combinations carry significant drug-supplement and drug-drug interaction risks. The PerformixHouse Editorial Team examines the safety of longevity stacking.
Metformin as a Longevity Drug: Interaction Profile
Metformin is a glucose-lowering medication that some longevity researchers and biohackers use off-label for anti-aging effects (based on observational studies showing metformin users have lower mortality). However, metformin has a narrow therapeutic window and several critical interactions:
Metformin-NSAIDs interaction: NSAIDs (ibuprofen, naproxen, indomethacin) reduce kidney function, impairing metformin clearance and increasing metformin levels dangerously. Combined use increases lactic acidosis risk (a rare but serious adverse effect). If you're using metformin, avoid NSAIDs; use acetaminophen instead.
Metformin-alcohol interaction: Chronic alcohol use impairs metformin metabolism and increases lactic acidosis risk. If supplementing with metformin, limit alcohol (no more than 1-2 drinks per day maximum).
Metformin-B12 interaction: Metformin reduces B12 absorption (via effects on calcium-dependent ileal B12 absorption). Chronic metformin use increases B12 deficiency risk. Biohackers using metformin should supplement with B12 (500 mcg daily oral, or 1000 mcg weekly) and monitor B12 levels annually.
Metformin and contrast dye: If undergoing any imaging requiring contrast dye, metformin must be discontinued for 24-48 hours and renal function reassessed before resuming (contrast can impair kidney function, raising lactic acidosis risk).
Safety guidance: If using metformin off-label for longevity, baseline kidney function testing (creatinine, eGFR) is essential. Repeat kidney function testing annually. Avoid NSAIDs, limit alcohol, and supplement with B12. Notify all healthcare providers that you're taking metformin—many procedures and medications require safety adjustments.
Rapamycin and mTOR Inhibitors: Serious Systemic Effects
Rapamycin (sirolimus) and its analogs (everolimus, temsirolimus) are immunosuppressant medications used to prevent transplant rejection. Some longevity researchers theorize that mTOR inhibition extends lifespan (based on animal models), and a small number of biohackers are obtaining rapamycin off-label. This is extremely risky.
Why: Rapamycin's effects are not limited to aging pathways. It suppresses immune function broadly, increasing infection risk (serious infections like tuberculosis, invasive fungal infections). It impairs wound healing, increases cardiovascular risk through lipid dysregulation, and can cause mouth sores, diarrhea, and chronic kidney disease. Using it without medical supervision and monitoring is genuinely dangerous.
Drug interactions: Rapamycin is metabolized by CYP3A4 and P-gp. Compounds that inhibit these (antifungals, some antibiotics, grapefruit juice, certain supplements) increase rapamycin levels dangerously. Compounds that induce CYP3A4 (St. John's Wort, rifampin, phenytoin) reduce rapamycin levels. The interaction list is extensive and complex—unsupervised use almost guarantees dangerous interactions.
Safety guidance: Do not use rapamycin off-label without direct medical supervision, regular blood work (kidney function, lipid panels, immune cell counts), and infectious disease screening. If considering rapamycin for longevity reasons, seek consultation with a longevity medicine specialist and understand fully the immunosuppressive risks.
Senolytics: Emerging Safety Unknowns
Senolytic compounds (theoretically clearing senescent cells) include fisetin, quercetin, dasatinib, and others. Few human trials exist, and long-term safety data is virtually absent. However, some (especially dasatinib, a tyrosine kinase inhibitor used in leukemia treatment) can cause serious effects at therapeutic doses: QT prolongation (arrhythmia risk), fluid retention, gastrointestinal bleeding.
The interaction problem: Natural senolytic compounds (quercetin, fisetin, resveratrol) are metabolized by CYP3A4 and other enzymes. Stacking them with each other, with metformin, or with other medications creates unpredictable interactions. Additionally, combining multiple compounds targeting cellular senescence without understanding how they interact is hypothesis-stacking—combining unproven interventions in ways that have never been tested in humans.
Safety guidance: If interested in senolytic supplementation, use single, well-studied compounds (fisetin from strawberries, quercetin from onions) in food form first. If supplementing, start low doses and assess tolerance. Do not stack multiple senolytics without specific medical supervision. Do not combine senolytics with metformin or rapamycin without explicit approval from your healthcare provider.
The Metformin-Rapamycin-Senolytic Stack: Not Recommended
Some biohackers combine metformin + rapamycin + senolytics (fisetin, quercetin, etc.), theorizing additive anti-aging effects. This combination is not recommended for several reasons:
1. No human trial has tested this combination's safety or efficacy
2. Metformin + rapamycin both affect kidney function and kidney disease risk is additive
3. Rapamycin + senolytics may have overlapping effects on immune function and senescent cell clearance, risking over-suppression
4. Interaction potential is high—four compounds affecting overlapping metabolic pathways
5. Long-term effects are unknown—combinations may cause unanticipated chronic effects
If pursuing aggressive longevity stacking, work with a physician who specializes in longevity medicine and can monitor you comprehensively (kidney function, immune markers, cardiovascular markers, cancer screening).
Blood Work Monitoring for Longevity Drug Users
If using any combination of longevity-targeted medications or supplements, comprehensive monitoring is essential:
Baseline: Complete metabolic panel (kidney function, liver function, glucose, electrolytes), lipid panel, CBC (complete blood count), fasting insulin, vitamin B12
Quarterly (first year): Repeat metabolic panel and CBC
Twice yearly (ongoing): Metabolic panel, CBC, lipids, vitamin B12
Annually: Cancer screening (age-appropriate), cardiovascular assessment, infection status
This is not optional if you're self-experimenting with drugs intended for disease management. Monitoring allows early detection of adverse effects before they become severe.
This article is for educational purposes and does not constitute medical advice. If you are considering off-label use of metformin, rapamycin, or other prescription medications for longevity purposes, this should only be done under direct medical supervision with comprehensive baseline and ongoing monitoring. Do not self-prescribe medications intended for disease management. If experiencing signs of infection, kidney dysfunction, or cardiovascular problems while supplementing with longevity compounds, seek immediate medical evaluation.
PerformixHouse.com Editorial Team | July 14, 2026
This article is for general information purposes only and does not constitute medical advice. Consult your doctor or qualified healthcare provider before making changes to your health routine.
Related reading: Peptide Supplements and Self-Experimentation: Legal Status, Contamination Risk, and Self-Injection Safety | Joint Supplement Safety 2026: Interactions and Cautions